SA53-OS

N/A

Report date: 2026/03/20 20:03:07
NMEFirst In Class

Base Information

Drug NameSA53-OS
Drug Alias NameSA53-OSSA53-MDM2AD-021SA53SA-53
ClassificationCell and gene therapy > Gene therapy
Mechanisms of Actionp53-binding protein Mdm-2 inhibitors
Targetsp53-binding protein Mdm-2
Therapy Area/IndicationsSolid tumoursNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesAdamed Pharma Sa
China Registration ClassN/A

Develop Information

Active CompaniesLamassu Bio Inc
Inactive CompaniesAdamed Pharma Sa
Active IndicationsSolid tumours
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A